Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes

dc.contributor.author	Can, G.
dc.contributor.author	Albayrak, S.
dc.contributor.author	Onat, A.
dc.contributor.author	Yazici, M.
dc.contributor.author	Karabulut, A.
dc.contributor.author	Hergenc, G.
dc.date.accessioned	2021-03-04T07:59:56Z
dc.date.available	2021-03-04T07:59:56Z
dc.identifier.citation	Hergenc G., Onat A., Can G., Yazici M., Karabulut A., Albayrak S., "Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes", 59th Annual Meeting of the American-Association-for-Clinical-Chemistry, California, Amerika Birleşik Devletleri, 15 - 19 Temmuz 2007, cilt.53
dc.identifier.other	vv_1032021
dc.identifier.other	av_6103f845-a44d-43a7-8c63-a2167abb4f2e
dc.identifier.uri	http://hdl.handle.net/20.500.12627/67671
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	TIBBİ LABORATUVAR TEKNOLOJİSİ
dc.title	Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	53
dc.contributor.firstauthorID	133968

Files in this item

Files	Size	Format	View
There are no files associated with this item.